Publication | Closed Access

Novel alantolactone derivative AL-04 exhibits potential anti-inflammatory activity via modulation of iNOS, COX-2 and NF-κB

InflammationDerivative Al-04Medicinal ChemistryAnti-inflammatoryPotential Anti-inflammatory ActivityMedicineImmunologyChronic InflammationPharmacological AgentPharmacotherapyPharmacologyInflammatory DiseaseDrug Discovery